FDA authorizes Pfizer booster dose for 12 to 17 year-olds

Jan 03, 2022

In other COVID developments, federal officials cleared two more rapid tests for emergency use as the weekly case average soared higher.

Stephanie Soucheray | News Reporter | CIDRAP NewsJan 03, 2022In other COVID developments, federal officials cleared two more rapid tests for emergency use as the weekly case average soared higher.Read More

Leave a Reply

Your email address will not be published.